Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
To the Editor:
Rosenstock et al. (July 27 issue)
1
report the efficacy and safety of once-weekly insulin icodec as compared with once-daily insulin glargine U100. Although rates of hypoglycemic events were low in both groups, it is noteworthy that three participants receiving insulin icodec had 105 of the 226 clinically significant hypogly...
Alternative Titles
Full title
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2879408110
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2879408110
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc2310221
